Molecules/SATRALIZUMAB

SATRALIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2020

Mechanism of action: IL6Ralpha/GP130 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

EnspryngRG6168SA-237SA237SAPELIZUMABSATRALIZUMABSATRALIZUMAB MWGESATRALIZUMAB-MWGE

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SATRALIZUMAB

Loading drug network...